Clinical trial CRO VivoSense positions itself as a complete wearable sensor CRO with proven capabilities in device vetting, data collection, cleaning, analysis, and compliant auditable data handling through its DHT platform, presenting a compelling upsell to biotechnology firms running digital health trials seeking end-to-end data solutions.

Strategic partnerships Recent and ongoing collaborations with pharma and research entities such as Otsuka in Japan and Cambridge Cognition highlight VivoSense’s ability to integrate with global partners, suggesting sales opportunities in multinational trials and cross-border digital health programs.

Sleep and neuro focus Publications and study launches around sleep assessment, Alzheimer’s disease, and cognitive/physical function measurement indicate a strong niche in neurology and psychiatry endpoints, presenting targeted upsell opportunities to sponsors focused on CNS conditions and real-world functional outcomes.

Real-world data core Emphasis on passive wearable data capture, real-world functional measures, and meaningful ecological assessments via MEADOW-AD studies signals value for sponsors seeking scalable, home-based data collection and patient-centric endpoints in diverse therapeutic areas.

Market positioning With revenue in the multi-millions and a mid-sized team, VivoSense offers a cost-effective, specialized alternative to larger CROs, appealing to mid-market biotech firms and digital health startups aiming for rapid deployments and compliant, auditable sensor data pipelines.